- AZURE-1 and AZURE-4 to form the basis of Mirum’s U.S. BLA Submission FOSTER CITY, Calif., March 05, 2026--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, ...

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced completion of enrollment in the Phase 3 AZURE-1 study and completion of screening in the Phase 3 AZURE-4 ...

LONG BEACH, CA, UNITED STATES, February 23, 2026 /EINPresswire.com/ — SCAN Health Plan (SCAN), one of the nation’s largest not-for-profit Medicare Advantage (MA ...

This program builds on that foundation and enables more brokers to help members access care and complete preventive services.” Older adults, particularly those with complex health needs, consistently ...

SCAN Health Plan is rolling out a new program that aims to train brokers to serve as better navigators in the member care journey. Through the Brokers as Health Navigators initiative, the insurer will ...